ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Editor Wine Reporting Awards

June 11, 1999

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001

In Brief: Cancer Center Scientist Set For Space Launch; NIH French Anderson Negotiating With USC

June 5, 1992